![Mary Reumuth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mary Reumuth
Geen lopende functies
Vermogen: - $ op 30-06-2026
Profiel
Mary E.
Reumuth worked as an Auditor at Ernst & Young LLP.
Served as Manager-External Financial Reporting at Genzyme Corp.
Worked as Finance Director at Verenium Corp.
from 2007 to 2011.
Held the position of Controller at Enobia Pharma, Inc. from 2011 to 2012.
Was Vice President-Finance & Controller at Kala Bio, Inc. from 2014 to 2017.
Served as Independent Director at Olink Holding AB from 2022 to 2024.
Completed undergraduate education at Texas A&M University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
KALA BIO, INC. -.--% | 23-10-2025 | 0 ( -.--% ) | - $ | 30-06-2026 |
Eerdere bekende functies van Mary Reumuth
| Bedrijven | Functie | Einde |
|---|---|---|
| KALA BIO, INC. | Financieel Directeur/CFO | 23-11-2025 |
| OLIK HLDG | Directeur/Bestuurslid | 01-08-2024 |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Comptroller/Controller/Auditor | 01-06-2012 |
| VERENIUM CORP | Financieel Directeur/CFO | 01-03-2011 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | - |
Opleiding van Mary Reumuth
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
56
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Kala Bio, Inc.
 Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enobia Pharma, Inc.
Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Health Technology |
Verenium Corp.
 Verenium Corp. BiotechnologyHealth Technology Produces cellulosic ethanol derived from multiple biomass feedstocks | Health Technology |
Olink Holding AB
 Olink Holding AB BiotechnologyHealth Technology Develops proteomics platform | Health Technology |
